Medtech Investor Support
DW Medtech Advisory, through its Medtech Matchmaker™ process, provides research, due diligence, and recommendations to qualify the right deal for investors. Potential investors in Medtech start-ups need to fully evaluate the disruptive and complex technologies that are new to the market, if not the world. The return on investment is heavily dependent on identifying the risks associated with the newly launched medical technology or process.
These risks can include unresolved design issues, inability to scale up manufacturing economically; difficulties with the intellectual property (both patents and know-how) for the product or process; compliance inconsistencies; or poor quality. The Medtech Matchmaker™ process assesses these factors in parallel and coordination with the financial due diligence team and coordinates a comprehensive risk management approach to qualify target companies. The result is to increase the likelihood of successful value creation.
The Medtech Matchmaker™ can assist investors by:
Medtech Companies Medtech Midwife™
Managing rapidly changing risk in the development and launch of MedTech products and solutions.
The Medtech Midwife™ can assist medical technology startups by providing an approach that will assure operating plans sync with market demands and forecasts.